Mark Mitchell
๐ค SpeakerAppearances Over Time
Podcast Appearances
And while Drury is still out on the long-term effects of GLP-1s, you can go with Drop.
It's a breakthrough peptide that targets the GLP-1 made by your own body.
The wellness company is always innovating.
So go to drdrew.com slash TWC to see what they have to offer and get a 10% discount there.
I'm excited to bring you a new product, a new supplement, Fatty.
I take it.
I make Susan take it.
My whole family takes it.
This comes out of, believe it or not, dolphin research.
The Navy maintains a fleet of dolphins, and a brilliant veterinarian recognized that these dolphins sometimes developed a syndrome identical to our Alzheimer's disease.
Those dolphins were deficient in a particular fatty acid.
She replaced the fatty acid
and they didn't get the Alzheimer's.
Humans have the same issue.
And we are more deficient in this particular fatty acid than ever before.
And a simple replacement of this fatty acid called C15 will help us prevent these syndromes.
Published in a recent journal called Metabolites, it's a new nutritional C15, pentadecanoic acid it's called.
The deficiency that we are developing for C15 creates something called the cellular fragility syndrome.
This is the first...
nutritional deficiency syndrome to be discovered in 75 years and may be affecting us in many ways and as many as one in three of us.